首页 | 本学科首页   官方微博 | 高级检索  
     


C/EBPalpha S248A mutation reduces granulocytic differentiation in human leukemic K562 cells
Authors:Singh Sheo M  Trivedi A K  Behre Gerhard
Affiliation:a Bone Marrow Transplantation Section, State Center for Cell and Gene Therapy, Department of Internal Medicine IV, Martin-Luther-University, Ernst Grube Str. 40, Halle 06097, Germany
b Department of Gene and Cell Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
c DTDD Division, Central Drug Research institute (CDRI), Lucknow 226001, India
Abstract:Phosphorylation of C/EBPα can either lead to granulocytic differentiation or a block in granulopoiesis. This dichotomy in effect is dependent on the upstream signaling pathway and the phosphorylation site in C/EBPα. Ras signaling induced phosphorylation of S248 residue of C/EBPα is known to enhance granulocytic differentiation. In this study, using β-estradiol inducible stable cell lines we show that the point mutation of phosphorylation site S248 in C/EBP disrupts the CD11b and GCSFr expression and subsequently reduces the differentiation of leukemic K562 cells. Based on our observations in the present study, we conclude that S248A mutation of C/EBPα leads to a reduction of granulocytic differentiation markers and a block in differentiation at the morphological level.
Keywords:C/EBPα   Acute myeloid leukemia   Granulocytes
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号